← Back to papers

Recent List of Cyclodextrin-Containing Drug Products

★ ★ ☆ ☆ ☆

Paper Summary

Paperzilla title
Big List of Drug Ingredients (Not Research!)

The paper presents a list of over 120 marketed pharmaceutical ingredients formulated with cyclodextrins or their derivatives, categorized by cyclodextrin cavity size, administration route, and dosage forms. The most commonly used are beta-cyclodextrin and its hydroxypropylated and sulfobutylated derivatives.

Explain Like I'm Five

Scientists found that lots of medicines have tiny helpers called cyclodextrins inside. These helpers make the medicine work better, and scientists listed over 120 of these special medicines.

Possible Conflicts of Interest

The authors work for CycloLab Cyclodextrin Research Ltd., which suggests a potential conflict of interest regarding cyclodextrin research. While not automatically invalidating the paper, this connection raises concerns about potential bias.

Identified Limitations

No original research or findings
The article is essentially a long table of drug ingredients and associated information. It does not formulate a novel hypothesis, establish a research methodology, present and analyze data, or arrive at original findings. It is an informative reference, but not an original scientific investigation.

Rating Explanation

While the topic may be of interest to some, the paper lacks original research, data analysis, and findings. Its format resembles a review or catalog. The authors' affiliation with a company directly involved in cyclodextrin research presents a potential conflict of interest. Overall, it does not meet the criteria for a scientific paper.

Good to know

This is the Starter analysis. Paperzilla Pro fact-checks every citation, researches author backgrounds and funding sources, and uses advanced AI reasoning for more thorough insights.

Explore Pro →

Topic Hierarchy

Domain: Life Sciences
Subfield: Pharmacology

File Information

Original Title: Recent List of Cyclodextrin-Containing Drug Products
Uploaded: July 14, 2025 at 11:16 AM
Privacy: Public